Yi Ding

7.8k total citations · 3 hit papers
286 papers, 5.6k citations indexed

About

Yi Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Yi Ding has authored 286 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 50 papers in Pulmonary and Respiratory Medicine and 41 papers in Pharmacology. Recurrent topics in Yi Ding's work include Sarcoma Diagnosis and Treatment (33 papers), Bone Tumor Diagnosis and Treatments (29 papers) and Pharmacological Effects of Medicinal Plants (16 papers). Yi Ding is often cited by papers focused on Sarcoma Diagnosis and Treatment (33 papers), Bone Tumor Diagnosis and Treatments (29 papers) and Pharmacological Effects of Medicinal Plants (16 papers). Yi Ding collaborates with scholars based in China, United States and Hong Kong. Yi Ding's co-authors include Aidong Wen, Yuwen Li, Tianlong Liu, Lijun Du, Minchun Chen, Jingwen Wang, Rufeng Wang, Hualin Jiang, Jingjie Zhao and Xinliang Xu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yi Ding

246 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effectiveness of virtual reality-based technology on anatomy teaching: a meta-analysis of randomized controlled studies

2020 254 citations Yi Ding et al. profile →
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma

2023 171 citations Yi Ding et al. profile →
Diabetes in China part 1: epidemiology and risk factors

2024 38 citations Mian Li, Qiuyu Cao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Ding China	39	2.0k	583	565	564	530	286	5.6k
Dongfeng Chen China	43	3.3k 1.6×	633 1.1×	825 1.5×	445 0.8×	699 1.3×	266	7.1k
Dong‐Seok Lee South Korea	46	3.1k 1.5×	482 0.8×	758 1.3×	588 1.0×	420 0.8×	273	6.9k
Niraj Kumar Jha India	51	3.3k 1.6×	747 1.3×	879 1.6×	463 0.8×	627 1.2×	281	9.1k
Ali H. Eid Qatar	49	2.8k 1.4×	528 0.9×	1.1k 1.9×	856 1.5×	636 1.2×	250	8.2k
Jianping Chen China	41	2.5k 1.2×	354 0.6×	329 0.6×	579 1.0×	260 0.5×	231	5.3k
Gianfranco Pintus Italy	46	2.8k 1.4×	422 0.7×	748 1.3×	545 1.0×	742 1.4×	159	7.2k
Hayder M. Al‐kuraishy Iraq	46	2.1k 1.0×	638 1.1×	1.2k 2.2×	629 1.1×	361 0.7×	369	7.2k
Joen‐Rong Sheu Taiwan	43	2.1k 1.0×	1.0k 1.7×	436 0.8×	342 0.6×	276 0.5×	233	6.0k
Yue Liu China	43	2.3k 1.1×	527 0.9×	1.3k 2.3×	681 1.2×	296 0.6×	323	6.5k
Imran Kazmi Saudi Arabia	42	2.5k 1.2×	411 0.7×	426 0.8×	356 0.6×	301 0.6×	296	6.3k

Countries citing papers authored by Yi Ding

Since Specialization

Citations

This map shows the geographic impact of Yi Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ding more than expected).

Fields of papers citing papers by Yi Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ding. The network helps show where Yi Ding may publish in the future.

Co-authorship network of co-authors of Yi Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ding. A scholar is included among the top collaborators of Yi Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ding. Yi Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Na, Tingting Fan, Li Liang, et al.. (2025). Brain-targeted delivery of Acetyl-11-Keto-β-Boswellic acid with enhanced anti-inflammatory efficacy via blood-brain barrier peptide shuttle PepH3. Chemical Engineering Journal. 509. 160664–160664. 2 indexed citations

Wei, Yang, et al.. (2025). Machine learning-driven prediction of axial capacity of concrete-filled steel tubes columns with built-in bamboo or timber cores. Engineering Structures. 341. 120817–120817. 5 indexed citations

Zhang, Xingfang, Hanxi Chen, Xinxin Liang, et al.. (2025). Identification and Validation of Antidepressant Small Molecules Using Bioinformatics and Mouse Depression Models. Drug Design Development and Therapy. Volume 19. 7161–7183.

Xu, Hairong, Feng Wei, Yi Ding, et al.. (2025). JMT103 versus Non‐Denosumab or Denosumab Treatment in Chinese Patients with Unresectable or Surgically Challenging Giant Cell Tumor of Bone: A Propensity Score‐Matched Comparison. Cancer Medicine. 14(22). e71340–e71340.

Zhang, Guodong, Lili Wang, Shiqi Wang, et al.. (2024). A novel HDAC6 inhibitor attenuate APAP-induced liver injury by regulating MDH1-mediated oxidative stress. International Immunopharmacology. 131. 111861–111861. 4 indexed citations

Tan, Lianmei, Tao Yin, Handan Xiang, et al.. (2024). Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response. Nature Communications. 15(1). 8569–8569. 10 indexed citations

Zhang, Xiaoli, Ye Tian, Dan Mo, et al.. (2024). The clinical impact of plasma estrogen receptor-1 mutation in patients with metastatic breast cancer: A meta-analysis. Advances in Clinical and Experimental Medicine. 33(11). 0–0. 1 indexed citations

Liu, Huan, et al.. (2024). Chemical Proteomics Reveals That Camptothecin Weakens Insect Immunity against Bacteria by Suppressing Antimicrobial Peptide Expression. Journal of Agricultural and Food Chemistry. 73(1). 289–297.

Huang, Dongdong, Huan Liu, Xiaolan Yin, et al.. (2024). A nanoformulation that enhance the efficiency of camptothecin against lepidopteran pests by controlled release and ‘poison bait’ strategies. Chemical Engineering Journal. 486. 150358–150358. 16 indexed citations

10.

Hu, Junping, et al.. (2023). Acteoside alleviates blood–brain barrier damage induced by ischemic stroke through inhibiting microglia HMGB1/TLR4/NLRP3 signaling. Biochemical Pharmacology. 220. 115968–115968. 12 indexed citations

11.

Wang, Jingwen, Chao Guo, Min Bai, et al.. (2023). Cistanche tubulosa alleviates ischemic stroke-induced blood-brain barrier damage by modulating microglia-mediated neuroinflammation. Journal of Ethnopharmacology. 309. 116269–116269. 16 indexed citations

12.

Cao, Qiuyu, Yi Ding, Yu Xu, et al.. (2023). Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116). Frontiers of Medicine. 17(6). 1068–1079. 7 indexed citations

13.

Liu, Tianlong, Wenjun Wang, Xiaolin Li, et al.. (2023). Advances of phytotherapy in ischemic stroke targeting PI3K/Akt signaling. Phytotherapy Research. 37(12). 5509–5528. 28 indexed citations

14.

Wang, Ziwen, Fei Ye, Yue Feng, et al.. (2021). Discovery and Nanosized Preparations of (S,R)-Tylophorine Malate as Novel anti-SARS-CoV-2 Agents. ACS Medicinal Chemistry Letters. 12(11). 1840–1846. 8 indexed citations

15.

Long, Pan, Tao Chen, Kaifeng Li, et al.. (2021). ALDH2/SIRT1 Contributes to Type 1 and Type 2 Diabetes‐Induced Retinopathy through Depressing Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2021(1). 1641717–1641717. 18 indexed citations

16.

Mu, Fei, Li Fei, Hạixia Chen, et al.. (2020). Potential mechanism study of herbal pair Schizonepetae Herba and Saposhnikoviae Radix against coronavirus pneumonia via network pharmacology and molecular docking. Tianran chanwu yanjiu yu kaifa. 32(7). 1087. 3 indexed citations

17.

Liu, Tianlong, Minna Liu, Tiejun Zhang, et al.. (2018). Z‐Guggulsterone attenuates astrocytes‐mediated neuroinflammation after ischemia by inhibiting toll‐like receptor 4 pathway. Journal of Neurochemistry. 147(6). 803–815. 31 indexed citations

18.

Ding, Yi, et al.. (2011). [Clinicopathologic features of primary osteosarcoma in elderly patients].. PubMed. 40(6). 373–6. 1 indexed citations

19.

Han, Xuejie, et al.. (2009). Theoretical study on the relationship between hypertension and combined phlegm and blood stasis and five zang viscera.. Zhonghua zhongyiyao zazhi. 24(3). 290–293. 1 indexed citations

20.

Ding, Yi. (2007). Treatment of Gastroesophageal Reflux Disease with Pantoprazole and Domperidone. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact